Department of Medicine
Faculty Profiles by Division

Division of Endocrinology and Metabolism

Faculty Profiles

[Return To Index page]
photo Esra Karslioglu French, MD, MBA, ECNU

Endocrinology and Metabolism

Clinical Associate Professor of Medicine

Endocrine Medical Director


Phone: 412-586-9700

Office: Falk Medical Bulding, Suite 3A
3601 Fifth Avenue
Pittsburgh, PA 15261
Phone: 412-586-9700
Fax: 412-586-9726
Administrative Assistant:
Maureen Cerda
Address: Falk Medical Bulding, Suite 3A
3601 Fifth Avenue
Pittsburgh, PA 15213
Phone: 412-864-1915
Fax: 412-523-9724
Education and Training
MD, Hacettepe Universitesi, Turkey, 2001
Residency, Internal Medicine, University of Pittsburgh Medical Center Shadyside, 2007
Endocrinology, Diabetes and Metabolism Fellowship, University of Pittsburgh, 2011
Research Interest
Dr Karslioglu-French`s research interests are: 1) Inpatient Hyperglycemia Management, 2)Thyroid Molecular Markers, and 3)Innovative Models of Health Care Delivery
Clinical Interest
Dr Karslioglu French is co-chair of diabetes patient safety committee where she develops systemwide diabetes management protocols and works on diabetes quality improvement projects with fellows.

Her second clinical interest is thyroid disease. She performs ultrasound guided thyroid biopsies in thyroid clinic. She provides care for thyroid eye disease patients in collaboration with ophthalmologists and endocrine surgeons.
Educational Interest
Dr. Karslioglu-French is interested in educating clinical Endocrine Fellows, Internal Medicine residents, and Medical Students.
Selected Publications:
Yip, L., Gooding, W. E., Nikitski, A., Wald, A. I., Carty, S. E., Karslioglu-French, E., Seethala, R. R., Zandberg, D. P., Ferris, R. L., Nikiforova, M. N., Nikoforov, Y. E. Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study. Cancer. 2021; Online Ahead of Print.
Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ. 2019; 365: I1114.
Puri S, Roy N, Russ H, Leonhardt L, Karslioglu French E, Roy R, Bengtsson H, Scott D, Stewart AF, Hebrok M. Replication confers ß cell immaturity. Nature Communications. 2018; 9(1): 485.
Korytkowski, M.T., Karslioglu, E., Brooks, M., Kanter, J., Lombardero, M., Magaji, V., Orchard, T., Siminerio, L. Use of an Electronic Medical Record to Identify Prevalent and Incident Cardiovascular Disease in Type 2 Diabetes According to Treatment Strategy. BMJ Open Diabetes Research & Care. 2016; 4(1).
Karslioglu, E., Kleinberger, J., Salim, F., Cox, A., Takane, K.K., Scott, D.K., Stewart, A.F. cMyc is the principal upstream driver of beta cell proliferation in rat insulinoma cell lines and is an effective mediator of human beta cell replication. Journal of Molecular Endocrinology. 2011; 25: 1760-72.
Korytkowski MT, Salata RJ, Koerbel GL, Selzer F, Karslioglu E, Idriss AM, Lee KK, Moser AJ, Toledo FG. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009; 32(4): 594-6.
Noschese M, Donihi AC, Koerbel G, Karslioglu E, Dinardo M, Curll M, Korytkowski MT. Effect of a diabetes order set on glycemic management and control in the hospital. Qual Saf Health Care. 2008; 17(6): 464-8.